Menu

News Room / Five Star Equities Issues New Research Reports on ETAK, SYN, SZYM and XOOM

Five Star Equities Issues New Research Reports on ETAK, SYN, SZYM and XOOM

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Elephant Talk Communications Corp. (NYSEMKT: ETAK) shares spiked 18.92 percent to close at $1.32 a share Wednesday. The stock traded between $1.12 and $1.36 on volume 2.73 million shares traded. The company reported revenue was $6.0 million for the fourth quarter of 2013, an increase of 64.0 percent when compared to a year ago. Shares of Elephant Talk Communications are up approximately 7.0 percent year-to-date.

Synthetic Biologics Inc. (NYSEMKT: SYN) shares fell 9.93 percent to close at $2.72 a share Wednesday. The stock traded between $2.59 and $3.04 on volume of 1.91 million shares traded. The company is scheduled to release results for the year end 2013 on Monday, March 31st. Shares of Synthetic Biologics are up approximately 77.0 percent year-to-date.

Solazyme Inc. (NASDAQ: SZYM) shares declined 11.80 percent to close at $11.55 a share Wednesday.The stock traded between $11.54 and $12.34 on volume of 6.45 million shares traded. The company announced plans to offer $100.0 million in convertible senior subordinated notes due 2019 and 5.0 million shares of its common stock in separate underwritten registered public offerings. Shares of Solazyme are up approximately 6.0 percent year-to-date.

Xoom Corp. (NASDAQ: XOOM) shares dropped 12.90 percent to close at $19.31 a share Wednesday. The stock traded between $18.88 and $22.32 on volume 1.55 million shares traded. The company recently presented at the Barclay's Emerging Payments Forum in New York, NY on Monday, March 24th. Shares of Xoom are down approximately 30.0 percent year-to-date.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.